Continuous Glucose Monitoring in Pediatric Diabetic Ketoacidosis

Thomas Pott1,2,3, Jose Jimenez-Vega2,4, Jessica Parker5

  • 1Division of Pediatric Critical Care, Helen DeVos Children's Hospital, Spectrum Health, Grand Rapids, MI, USA.

Insights

Real-time continuous glucose monitoring (rtCGM) is feasible and reliable for children hospitalized with diabetic ketoacidosis (DKA). This technology accurately tracks glucose levels during DKA treatment, aiding in pediatric intensive care.

Area of Science:

  • Pediatric Endocrinology
  • Medical Technology Assessment
  • Diabetes Management

Background:

  • Real-time continuous glucose monitoring (rtCGM) improves glycemic control in type 1 diabetes (T1D) but its use in pediatric DKA is understudied.
  • Diabetic ketoacidosis (DKA) is a serious complication of T1D requiring intensive management.

Purpose of the Study:

  • To assess the accuracy, reliability, and feasibility of rtCGM in pediatric patients with DKA.
  • To compare rtCGM glucose readings with point-of-care (POC) capillary and serum glucose values.
  • To evaluate the relationship between rtCGM accuracy and the degree of acidosis.

Main Methods:

  • Prospective, single-arm, single-center study involving 35 hospitalized children with DKA.
  • Comparison of rtCGM values against POC capillary and serum glucose measurements.
  • Accuracy assessed using Clarke Error Grid (CEG) analysis.

Main Results:

  • High accuracy of rtCGM was observed, with 95.4% of paired values within clinically acceptable zones (A+B) compared to POC capillary glucose and 95.6% compared to serum glucose.
  • Mean length of hospital stay was 1.32 days.
  • Acidosis severity, indicated by serum bicarbonate levels, did not significantly impact rtCGM accuracy.

Conclusions:

  • rtCGM is a feasible and reliable tool for monitoring glucose levels in pediatric patients during inpatient DKA treatment.
  • The findings support the expanded use of rtCGM in pediatric intensive care settings for DKA management.
Abstract

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
311
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.6K
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
2.0K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
648
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
1.4K
Diagnosing Acidosis and Alkalosis01:24

Diagnosing Acidosis and Alkalosis

Diagnosing acid-base imbalances involves systematically analyzing arterial blood samples, focusing on three key measurements: pH, bicarbonate (HCO3−) concentration, and carbon dioxide partial pressure (PCO2). This analysis follows a four-step process that helps identify the imbalance's underlying cause and nature.
First, the pH level is assessed to determine whether the blood pH is normal (7.35–7.45), low (acidosis), or high (alkalosis).
Next, the PCO2  and...
458